Oncology Pharma Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session.

The Oncology Pharma Inc. stock price gained 3.90% on the last trading day (Wednesday, 21st Jul 2021), rising from $26.65 to $27.69. , and has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.43% from a day low at $26.88 to a day high of $28.07. The price has risen in 6 of the last 10 days, but is still down by -2.81% for this period. Volume fell on the last day by -47 thousand shares and in total, 256 thousand shares were bought and sold for approximately $7.07 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.Given the current short-term trend, the stock is expected to fall -7.95% during the next 3 months and, with a 90% probability hold a price between $15.47 and $32.38 at the end of this 3-month period.

There are mixed signals in the stock today. The Oncology Pharma Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $28.49. On a fall, the stock will find some support from the short-term average at $24.96. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Thursday, July 15, 2021, and so far it has risen 32.17%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

On the downside, the stock finds support just below today's level from accumulated volume at $25.10 and $25.00.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma Inc. finds support just below today's level at $25.10. If this is broken, then the next support from accumulated volume will be at $25.00 and $20.95.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.19 between high and low, or 4.43%. For the last week, the stock has had a daily average volatility of 9.49%.

Oncology Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.